Protalix Biotherapeutics Inc. (PLX)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Shaaltiel Officer, Director	$7.00	50,000	$350,000.00	883,754	2010-03-25	Filing
Shaaltiel Officer, Director	$7.08	202,700	$1,435,116.00	933,754	2010-03-24	Filing
Shaaltiel Officer, Director	$7.02	127,300	$893,646.00	1,136,454	2010-03-23	Filing
Hurvitz Director	$10.76	250,000	$2,690,000.00	1,514,480	2009-11-12	Filing
Hurvitz Director	$10.00	1,121,967	$11,219,670.00	1,764,480	2009-11-12	Filing
Aviezer Officer, Director	$9.36	34,238	$320,467.68	0	2009-10-21	Filing
Aviezer Officer, Director	$9.45	60,000	$567,000.00	0	2009-10-20	Filing
Aviezer Officer, Director	$9.43	150,000	$1,414,500.00	0	2009-10-19	Filing
Almon Officer	$9.43	38,320	$361,357.60	0	2009-10-19	Filing
Almon Officer	$9.39	23,680	$222,355.20	0	2009-10-16	Filing
Almon Officer	$9.39	28,000	$262,920.00	0	2009-10-15	Filing
Shaaltiel Officer, Director	$9.43	43,120	$406,621.60	1,263,754	2009-10-19	Filing
Shaaltiel Officer, Director	$9.39	25,680	$241,135.20	1,306,874	2009-10-16	Filing
Shaaltiel Officer, Director	$9.39	31,200	$292,968.00	1,332,554	2009-10-15	Filing
Maimon Officer	$9.35	40,300	$376,805.00	0	2009-10-16	Filing
Maimon Officer	$9.50	109,700	$1,042,150.00	0	2009-10-15	Filing
Frost Large Shareholder	$7.55	974	$7,353.70	7,610,167	2009-09-10	Filing
Frost Large Shareholder	$7.54	2,300	$17,342.00	7,611,141	2009-09-10	Filing
Frost Large Shareholder	$7.53	1,700	$12,801.00	7,613,441	2009-09-10	Filing
Frost Large Shareholder	$7.52	1,100	$8,272.00	7,615,141	2009-09-10	Filing